BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16687391)

  • 1. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
    Xiao S; Anderson SP; Swanson C; Bahnemann R; Voss KA; Stauber AJ; Corton JC
    Toxicol Sci; 2006 Aug; 92(2):368-77. PubMed ID: 16687391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
    Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
    Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
    Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
    Laughter AR; Dunn CS; Swanson CL; Howroyd P; Cattley RC; Corton JC
    Toxicology; 2004 Oct; 203(1-3):83-98. PubMed ID: 15363585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of peroxisome proliferator-activated receptor alpha-regulated genes in dwarf mice.
    Stauber AJ; Brown-Borg H; Liu J; Waalkes MP; Laughter A; Staben RA; Coley JC; Swanson C; Voss KA; Kopchick JJ; Corton JC
    Mol Pharmacol; 2005 Mar; 67(3):681-94. PubMed ID: 15576629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
    Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
    Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
    Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator BR931 kills FaO cells by p53-dependent apoptosis.
    Simbula G; Pibiri M; Sanna L; Cossu C; Molotzu F; Columbano A; Ledda-Columbano GM
    Life Sci; 2004 Jun; 75(3):271-86. PubMed ID: 15135649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643.
    Giometti CS; Tollaksen SL; Liang X; Cunningham ML
    Electrophoresis; 1998 Oct; 19(14):2498-505. PubMed ID: 9820974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
    Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
    Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
    Rusyn I; Yamashina S; Segal BH; Schoonhoven R; Holland SM; Cattley RC; Swenberg JA; Thurman RG
    Cancer Res; 2000 Sep; 60(17):4798-803. PubMed ID: 10987289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
    Pogribny IP; Tryndyak VP; Woods CG; Witt SE; Rusyn I
    Mutat Res; 2007 Dec; 625(1-2):62-71. PubMed ID: 17586532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T; Tsunoda M; Mochizuki T; Murakami K
    Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of phase I and phase II steroid metabolism enzymes by PPAR alpha activators.
    Fan LQ; You L; Brown-Borg H; Brown S; Edwards RJ; Corton JC
    Toxicology; 2004 Nov; 204(2-3):109-21. PubMed ID: 15388238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.